5 years after it was removed, industry and suppliers think it has been a good thing that it is no longer used as indicated in the following article
Thrainsdottir I, Malmberg K, Olsson A, Gutniak M, Ryden L: Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure
For ongoing support a maintenance schedule of one injection every four to twelve weeks is common, agreed at your free consultation
Gallstones: These can happen in people with significant weight loss
Weight trend smoothing helps you see the direction of travel instead of overreacting to one weigh-in useful on a GLP-1 where weekly fluctuations are normal
All data are from the VUMC Synthetic Derivative (SD) database, a de-identified copy of the main hospital medical record database created for research purposes